𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Longitudinal ADC changes in Alzheimer's disease in a multicenter clinical trial setting

✍ Scribed by Luc Bracoud; Angelika Caputo; Chahin Pachai; Boubakeur Belaroussi; Ana Graf; Paul Maguire

Book ID
118466924
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
53 KB
Volume
7
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of longitudinal data in an Alzh
Analysis of longitudinal data in an Alzheimer's disease clinical trial
✍ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 2 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a

Multicenter trial of naloxone in alzheim
Multicenter trial of naloxone in alzheimer's disease
✍ Dr. V. W. Henderson; E. Roberts; C. Wimer; E. L. Bardolph; H. C. Chui; A. R. Dam πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 312 KB πŸ‘ 2 views